Candice Jones focuses her practice on patent litigation, patent prosecution, and client counseling in the areas of biotechnology and pharmaceuticals. Candice has a particular interest in the cosmetics and medical device industries. Her experience includes U.S. district court litigations, primarily concerning Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Additionally, Candice assists with the preparation and prosecution of U.S. patent applications, including design patent applications, on behalf of domestic and foreign clients.
Prior to attending law school, Candice spent more than a decade in the biotechnology arena as a scientist. She began as a post-baccalaureate research fellow at the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). After completing her NIAID fellowship, Candice was awarded a competitive grant from the NIH, National Institute of General Medical Sciences (NIGMS), and conducted research at Johns Hopkins University. Throughout her career, Candice has worked at several notable biopharmaceutical corporations, focusing on researching, developing, and designing novel adenovector-based therapeutics and vaccines, using a gene delivery platform; and designing innovative custom assays, for market, in the fields of molecular biology and genomics. Candice also has an extensive background in high-throughput, cutting-edge, molecular biology techniques, utilizing automation. During her graduate studies, Candice’s thesis work focused on Bacteriophage Mu Derepression and the Effect of SsrA Tagged Repressor Peptides.
Candice also served as an adjunct professor at Howard University School of Law from 2017 to 2020, co-teaching Current Topics in Patent Law: Public Policy, Public Service, and Social Engineering Implications in the 21st Century and Introduction to Patent Law.